ArticleBreast cancer (Tokyo, Japan)2025
Stereotactic radiosurgery for HER2-positive breast cancer brain metastases: prognostic factors and the evolving role of anti-HER2 therapies.
Menekse Turna et al.PubMed ↗Publisher ↗
No numbers read from the abstract.